Mechanism of Gancao Fuzi Decoction in the treatment of Rheumatoid Arthritis

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease that results in a series of inflammatory reactions in the joints, marked by pathologies such as articular bone destruction and erosive synovial inflammatory cartilage [1]. The bone destruction in RA arises from an imbalance between bone resorption by osteoclasts and bone formation by osteoblasts [2]. The pathogenesis of RA remains unknown, and studies have indicated its close relationship with genetics, the environment, immune response, and other factors. Potential genes linked to RA susceptibility include major histocompatibility complex genes, like the single nucleotide polymorphism rs9277535 in the HLA-DP subunit HLA-DPB1, which is strongly associated with RA susceptibility in the Western Chinese population [3]. Furthermore, studies have also identified a correlation between major genes encoding the inflammatory CASPs (CASP1, CASP4, and CASP5) and RA [4]. Environmental factors, including smoking, diet, obesity, and infections, have the ability to trigger RA in susceptible individuals [5, 6]. Regarding the immune response, both immune dysregulation and overactivity can result in an inflammatory response, leading to excessive proliferation of synovial tissue, imbalanced distribution of osteoblasts and osteoclasts, and an irregular proportion of immune cells, culminating in the disease. RA is classified within the arthralgia syndrome according to Traditional Chinese Medicine, and Gancao Fuzi Decoction (GCFZD), a remedy documented over 2,000 years ago in The Synopsis of the Golden Chamber for treating this ailment, has demonstrated its efficacy in clinical practice as confirmed by most traditional Chinese medicine practitioners [7]. Drawing from the accumulated experiences of these treatments, the author presents a summary of the available evidence for this therapeutic approach.